Status:

COMPLETED

The 2021-2022 Study of Family and Staff Well-Being in Head Start AIAN FACES Programs

Lead Sponsor:

Mathematica Policy Research, Inc.

Collaborating Sponsors:

Department of Health and Human Services

Office of Planning, Research & Evaluation

Conditions:

Head Start Participation

Eligibility:

All Genders

2+ years

Brief Summary

The 2021-2022 Study of Family and Staff Experiences in American Indian and Alaska Native Head Start Family and Child Experiences Survey Programs (the 2021-2022 Study) builds on AIAN FACES 2019, a nati...

Detailed Description

The American Indian and Alaska Native Head Start Family and Child Experiences Survey (AIAN FACES) provides information about children and families enrolled in Head Start programs operated by federally...

Eligibility Criteria

Inclusion

  • The Head Start programs participating in the 2021-2022 Study were a probability sample selected from among 146 study-eligible programs on the 2016-2017 Head Start Program Information Report (PIR). To be eligible for the study, a program had to be
  • providing services directly to children ages 3 to 5
  • o The Head Start Program Performance Standards require that children turn 3 by date used to determine eligibility for public school in the community in which the Head Start program is located. Therefore, some study children were 2 years old at the time of sampling if sampling occurred before the date used for public school eligibility.
  • not be in imminent danger of losing its grantee status. Probability samples of centers were selected within each program, teachers within each center, and children within each teacher. Further, the programs that participated in the 2019-2020 study had to have participated in AIAN FACES 2019-2020.

Exclusion

  • Head Start programs in Regions I through X and Migrant and Seasonal Head Start (Region XII) were not eligible for the 2021-2022 Study. Programs that did not participate in AIAN FACES 2019-2020 were also not eligible for this study.

Key Trial Info

Start Date :

August 2 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

560 Patients enrolled

Trial Details

Trial ID

NCT06510218

Start Date

August 2 2021

End Date

July 31 2022

Last Update

July 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mathematica

Washington D.C., District of Columbia, United States, 20002